We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PANEL RECOMMENDS APPROVAL FOR EXPANDED CRT-D INDICATIONS
PANEL RECOMMENDS APPROVAL FOR EXPANDED CRT-D INDICATIONS
July 30, 2004
The potential market for Guidant’s cardiac resynchronization therapy defibrillators (CRT-D) could grow by approximately 40 percent if the FDA follows the lead of its Circulatory System Devices Panel, which voted Wednesday to recommend approval for expanded indications for the devices.